SomnoMed Limited (SOM.AX)
AUD 0.53
(1.92%)
AUD 0.53
(1.92%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -15.16 Million AUD | -181.87% |
| 2023 | 11.55 Million AUD | 417.95% |
| 2022 | -3.63 Million AUD | 70.22% |
| 2021 | -12.2 Million AUD | 16.68% |
| 2020 | -14.64 Million AUD | -257.03% |
| 2019 | -4.1 Million AUD | 65.67% |
| 2018 | -11.94 Million AUD | 15.19% |
| 2017 | -14.08 Million AUD | 20.1% |
| 2016 | -17.63 Million AUD | -112.29% |
| 2015 | -8.3 Million AUD | -182.03% |
| 2014 | -2.94 Million AUD | 30.24% |
| 2013 | -4.22 Million AUD | -19.33% |
| 2012 | -3.53 Million AUD | 10.41% |
| 2011 | -3.94 Million AUD | 7.9% |
| 2010 | -4.28 Million AUD | -6.95% |
| 2009 | -4 Million AUD | 26.21% |
| 2008 | -5.43 Million AUD | -74.52% |
| 2007 | -3.11 Million AUD | -51.15% |
| 2006 | -2.05 Million AUD | 66.91% |
| 2005 | -6.22 Million AUD | -12038.18% |
| 2004 | -51.27 Thousand AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | -15.16 Million AUD | 0.0% |
| 2024 FY | -9.45 Million AUD | -181.87% |
| 2024 Q2 | 5.7 Million AUD | 0.0% |
| 2023 FY | 11.55 Million AUD | 417.95% |
| 2023 Q4 | 11.55 Million AUD | 0.0% |
| 2023 Q2 | 6.1 Million AUD | 0.0% |
| 2022 Q4 | -3.63 Million AUD | 0.0% |
| 2022 Q2 | -9.39 Million AUD | 0.0% |
| 2022 FY | -3.63 Million AUD | 70.22% |
| 2021 FY | -12.2 Million AUD | 16.68% |
| 2021 Q2 | -15.42 Million AUD | 0.0% |
| 2021 Q4 | -12.2 Million AUD | 0.0% |
| 2020 Q2 | 1.57 Million AUD | 0.0% |
| 2020 Q4 | -14.64 Million AUD | 0.0% |
| 2020 FY | -14.64 Million AUD | -257.03% |
| 2019 Q4 | -4.1 Million AUD | 0.0% |
| 2019 Q2 | -7.44 Million AUD | 0.0% |
| 2019 FY | -4.1 Million AUD | 65.67% |
| 2018 Q2 | -6.9 Million AUD | 0.0% |
| 2018 FY | -11.94 Million AUD | 15.19% |
| 2018 Q4 | -11.94 Million AUD | 0.0% |
| 2017 Q4 | -14.15 Million AUD | 0.0% |
| 2017 Q2 | -16.71 Million AUD | 0.0% |
| 2017 FY | -14.08 Million AUD | 20.1% |
| 2016 Q4 | -17.63 Million AUD | 0.0% |
| 2016 FY | -17.63 Million AUD | -112.29% |
| 2016 Q2 | -7.42 Million AUD | 0.0% |
| 2015 FY | -8.3 Million AUD | -182.03% |
| 2015 Q2 | -8.95 Million AUD | 0.0% |
| 2015 Q4 | -8.3 Million AUD | 0.0% |
| 2014 Q2 | -3.96 Million AUD | 0.0% |
| 2014 Q4 | -2.94 Million AUD | 0.0% |
| 2014 FY | -2.94 Million AUD | 30.24% |
| 2013 FY | -4.22 Million AUD | -19.33% |
| 2013 Q2 | -3.53 Million AUD | 0.0% |
| 2013 Q4 | -4.22 Million AUD | 0.0% |
| 2012 Q4 | -3.53 Million AUD | 0.0% |
| 2012 FY | -3.53 Million AUD | 10.41% |
| 2011 Q4 | -3.94 Million AUD | 0.0% |
| 2011 FY | -3.94 Million AUD | 7.9% |
| 2010 FY | -4.28 Million AUD | -6.95% |
| 2010 Q4 | -4.29 Million AUD | 0.0% |
| 2009 FY | -4 Million AUD | 26.21% |
| 2009 Q4 | -4 Million AUD | 0.0% |
| 2008 FY | -5.43 Million AUD | -74.52% |
| 2008 Q4 | -5.43 Million AUD | 0.0% |
| 2007 Q4 | -3.11 Million AUD | 0.0% |
| 2007 FY | -3.11 Million AUD | -51.15% |
| 2006 FY | -2.05 Million AUD | 66.91% |
| 2006 Q4 | -2.05 Million AUD | 0.0% |
| 2005 FY | -6.22 Million AUD | -12038.18% |
| 2005 Q4 | -6.22 Million AUD | 0.0% |
| 2004 FY | -51.27 Thousand AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 40.504% |
| Adherium Limited | -6.1 Million AUD | -148.395% |
| Aroa Biosurgery Limited | -3.74 Million AUD | -304.65% |
| Atomo Diagnostics Limited | -3.6 Million AUD | -320.802% |
| Anteris Technologies Ltd | -28.49 Million AUD | 46.795% |
| Control Bionics Limited | -19.02 Thousand AUD | -79612.07% |
| CardieX Limited | 2.74 Million AUD | 652.114% |
| Compumedics Limited | 5.08 Million AUD | 398.07% |
| Cochlear Limited | -269.9 Million AUD | 94.382% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | 2270.484% |
| Cyclopharm Limited | -7.49 Million AUD | -102.195% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | 3.429% |
| Nova Eye Medical Limited | -2.8 Million AUD | -441.143% |
| HeraMED Limited | -799.34 Thousand AUD | -1796.9% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 204.695% |
| ImpediMed Limited | -23.48 Million AUD | 35.447% |
| InhaleRx Limited | -155.54 Thousand AUD | -9648.258% |
| LBT Innovations Limited | -604 Thousand AUD | -2410.402% |
| Micro-X Limited | 826.99 Thousand AUD | 1933.476% |
| Neurotech International Limited | -2.11 Million AUD | -618.454% |
| OncoSil Medical Limited | -4.43 Million AUD | -242.22% |
| PolyNovo Limited | -30.52 Million AUD | 50.33% |
| Respiri Limited | 413.68 Thousand AUD | 3765.273% |
| Universal Biosensors, Inc. | -5.3 Million AUD | -185.878% |
| Uscom Limited | -1.53 Million AUD | -890.625% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | -271.369% |